Press Releases
- Aug 23, 2004Mylan Also Announces Tentative Approval for Cetirizine Hydrochloride Tablets and Sertraline Hydrochloride Tablets
- Aug 20, 2004
- Aug 18, 2004
- Jul 29, 2004
- Jul 26, 2004Financial Highlights:
- Jul 26, 2004$4 Billion Stock-For-Stock Transaction To Create New Leader in Specialty Pharmaceutical Industry
- Jun 28, 2004
- Jun 17, 2004
- May 11, 2004Annual Financial Highlights: * Record diluted earnings per share of $1.21 compared to $0.96 in the prior fiscal year. * Net revenues increased 8% to a record $1.37 billion. * Net earnings increased 23% to a record $334.6 million.
- May 5, 2004